NEWSLETTER SUBSCRIBE

Medtech Startup Showdown 2017: Round 2—MedicusTek USA Corporation vs UVision 360

 MedicusTek USA Corp. vs.UVision 360 

 

 

Describe your device and how it will benefit healthcare.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MedicusTek has developed the Sensable Care System, a sensor technology solution in the form of a sensor mattress or pad to detect patient bed movement. The collected data is used to inform clinicians of potential patient safety scenarios such as a bed fall or a pressure injury before they occur and alert caregivers when it is time to reposition a patient. As sensors detect activity on the bed, this data is sent wirelessly to the nursing station monitor (dashboard) for analysis. If a safety issue is detected, appropriate alerts are sent to caregivers’ mobile devices.

The Sensable Care System uses predictive algorithms to detect potential bed exits in four stages: stirring, sitting up, leaving and out of bed. The system can also detect pressure between the patient and the sensors, and visually maps the pressure points for clinicians to view at the dashboard or on their mobile device. When a potential bed exit or a need for repositioning is detected, the system sends an alert to the dashboard and nurses’ mobile devices, prompting caregivers to intervene. 

 

 

UVision360 Inc. (“UVision”) is focused on the simplification of hysteroscopic systems, especially for the office setting. The system includes a reusable slim-line hysteroscope and our unique disposable 360° cannula. UVision360 offers an all-in-one office system with a patented rotatable cannula providing a 360°, 30-mm depth of view, high-definition optics, integrated fluid management, and an operating channel. This allows gynecologists to perform global hysteroscopic procedures with superior visualization due to our high-definition optics and integrated flow system. The operative channel enables therapeutic procedures that can be done in the office. The system works with off-the-shelf monitors and computer systems. UVision’s hysteroscopy system enables office-based gynecological procedures such as diagnostic hysteroscopy, directed biopsy, fallopian tubal occlusion for permanent sterilization using currently marketed devices, and other outpatient surgical procedures that are currently performed in the ASC or hospital setting. Female cystoscopy will also be able to be performed with the current scope system.

 

 

How does your product differ from the competition?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current bed alarm systems usually are triggered when the patient is leaving the bed or is already out of the bed. As a result, nurses often have insufficient time to intercept a bed fall. Since the Sensable Care System can detect potential bed exits in multiple stages, it is able to provide nurses with an actionable response time to intercept potential bed falls before they occur.

The system also addresses alarm fatigue faced by nursing staff. According to our clinical studies, more than seven out of 10 alerts generated by our innovation are true alerts. This rate is much higher than many of the patient monitoring systems currently in place at healthcare facilities. We also reduce alarm fatigue by making alerts customizable per patien to reduce the number of unnecessary alerts nurses receive, so that each alert triggered by the Sensable Care System elicits an actionable response.

In many hospitals, nurses are required to reposition their patients every two hours. However, it is difficult for the nursing staff to determine if the pressure in one area has been fully relieved during repositioning. The Sensable Care System provides a visual map of each patient’s positioning on the bed, and indicates the pressure accumulated between the patient’s body and the sensors. Nurses can reference this map when repositioning the patient to ensure that pressure is properly relieved.

The Sensable Care System also frees caregivers to perform other tasks by continuously monitoring any unrelieved pressure between the patient and the mattress. If a patient moves and successfully repositions themselves, the timer resets and the nurse can concentrate on taking care of the patient in other ways. Similarly, our system allows for automatic documentation of repositioning events, freeing up additional nurse time and effort.

Our Sensable Care System can help to diagnose the workflow efficiency of healthcare institutes by tracking when and how often each alert is triggered, and how long it took for nursing staff to respond. The system also tracks when and how each patient is repositioned. This increases accountability in the nursing workflow, and can inform management on staffing quality and levels. Our data analysis generates regular reports that can be referenced in making decisions about hospital operations and staffing.

The Sensable Care System reduces the amount of time a caregiver needs to spend watching over a patient. In hospitals, sitters are hired to ensure that a high fall risk patient doesn’t hurt themselves when they try to get out of bed. By continuously monitoring a patient 24/7, the Sensable Care System does not get tired and it can alert a caregiver with enough time to intervene before a patient is out of bed.

The technology saves money by giving an excellent return on investment. It can prevent bed falls and pressure injuries before they occur, which typically costs on average $14,000 and $44,000 per respective incident. CMS no longer reimburses hospitals for injuries that occur when a patient is injured while under the care hospital’s care. By using Sensable Care to prevent bed falls and pressure injuries, hospitals can prevent these charges from occurring and can lower the likelihood that they be assessed a penalty for having lower quality scores than their peers.

 

 

 

 

 

 

 

Tower systems that cost $30,000 plus licensing and servicing contracts are currently available but financially prohibitive. EndoSee Medical, now a part of Cooper Surgical, is the only other targeted, office-based product. The EndoSee device is useful for only diagnostic procedures (no therapeutic capabilities) and no outflow fluid management, with less visualization due to the small screen. Our product is geared to the in-office hysteroscopist with an all-in-one system for under $6000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Do you have customers yet?

 

 

 

 

 

 

Our product is currently being piloted. Because going into hospitals requires getting into a GPO to make direct sales, we are currently doing pilots to enter these healthcare facilities.

We are coming out of clinical trials, most recently a 6000 patient-day studio in a Joint Commission International accredited hospital in Taiwan and a teaching hospital in Massachusetts.

 

 

 

Product is currently in validation testing and expected to launch in 4Q17

 

 

 

 

 

 

 

How much money have you raised?

 

 

We have raised approximately $9M to date.

 

 

 

 

$1.9MM in Series A

$250,000 Small Business Loan from the North Carolina Biotechnology Center

 

Who are your investors?

 

 

 

Angel funds and angel investors

 

What is the next milestone for your device?

 

 

 

We are piloting our device in hospitals in Southern California. We will be starting at Kaiser's Downey Medical Center in Q2 2017.

 

 

 

 

FDA submission and approval

 

 

 

 

 

 

(function(t,e,n,o){var s,c,r;t.SMCX=t.SMCX||[],e.getElementById(o)||(s=e.getElementsByTagName(n),c=s[s.length-1],r=e.createElement(n),r.type="text/javascript",r.async=!0,r.id=o,r.src=["https:"===location.protocol?"https://":"http://","widget.surveymonkey.com/collect/website/js/YftNYqt8vwA2ZArDG_2BGtHGTmJSAtVPTLkZQMdmY4gETkD68K_2FfQ7x1z9HnnyoQfa.js"].join(""),c.parentNode.insertBefore(r,c))})(window,document,"script","smcx-sdk");

Create your own user feedback survey

 

        

Continue on to see the original 16 finalists in the Medtech Startup Showdown 2017

 

Device talk Tags:

» More Information

« Go to Technological Watch




This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement N° 690103